Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Forecasting the COVID-19 Pandemic: Lessons learned and future directions

View ORCID ProfileSaketh Sundar, View ORCID ProfilePatrick Schwab, Jade Z.H. Tan, Santiago Romero-Brufau, Leo Anthony Celi, Dechen Wangmo, Nicolás Della Penna
doi: https://doi.org/10.1101/2021.11.06.21266007
Saketh Sundar
1MIT Critical Data, Massachusetts Institute of Technology, Cambridge, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Saketh Sundar
Patrick Schwab
2GlaxoSmithKline, Artificial Intelligence & Machine Learning, Zug, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick Schwab
Jade Z.H. Tan
3U.S. Department of Health and Human Services (HHS)*
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Santiago Romero-Brufau
4Department of Medicine, Mayo Clinic, Rochester, MN, USA
5Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leo Anthony Celi
1MIT Critical Data, Massachusetts Institute of Technology, Cambridge, MA
5Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA
6Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA
7Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dechen Wangmo
8Ministry of Health, Royal Government of Bhutan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolás Della Penna
9Amurado Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: n@nikete.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

I. Abstract

The Coronavirus Disease 2019 (COVID-19) has demonstrated that accurate forecasts of infection and mortality rates are essential for informing healthcare resource allocation, designing countermeasures, implementing public health policies, and increasing public awareness. However, there exist a multitude of modeling methodologies, and their relative performances in accurately forecasting pandemic dynamics are not currently comprehensively understood.

In this paper, we introduce the non-mechanistic MIT-LCP forecasting model, and assess and compare its performance to various mechanistic and non-mechanistic models that have been proposed for forecasting COVID-19 dynamics. We performed a comprehensive experimental evaluation which covered the time period of November 2020 to April 2021, in order to determine the relative performances of MIT-LCP and seven other forecasting models from the United States’ Centers for Disease Control and Prevention (CDC) Forecast Hub.

Our results show that there exist forecasting scenarios well-suited to both mechanistic and non-mechanistic models, with mechanistic models being particularly performant for forecasts that are further in the future when recent data may not be as informative, and non-mechanistic models being more effective with shorter prediction horizons when recent representative data is available. Improving our understanding of which forecasting approaches are more reliable, and in which forecasting scenarios, can assist effective pandemic preparation and management.

Competing Interest Statement

Patrick Schwab is an employee and shareholder of GlaxoSmithKline plc. Jade Z.H. Tan is an employee of the U.S. Department of Health and Human Services (HHS).

Funding Statement

No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • * Disclaimer: Jade Z.H. Tan contributed to this in their private capacity. The views expressed in this paper do not represent the views of or endorsement by the United States Government or the U.S. Department of Health and Human Services

Data Availability

All scripts used for forecasting and production of data are located at: https://github.com/sakethsundar/covid-forecaster. All data used for analysis was obtained from the CDC forecast hub repository at: https://github.com/reichlab/covid19-forecast-hub/tree/master/data-processed.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted November 09, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Forecasting the COVID-19 Pandemic: Lessons learned and future directions
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Forecasting the COVID-19 Pandemic: Lessons learned and future directions
Saketh Sundar, Patrick Schwab, Jade Z.H. Tan, Santiago Romero-Brufau, Leo Anthony Celi, Dechen Wangmo, Nicolás Della Penna
medRxiv 2021.11.06.21266007; doi: https://doi.org/10.1101/2021.11.06.21266007
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Forecasting the COVID-19 Pandemic: Lessons learned and future directions
Saketh Sundar, Patrick Schwab, Jade Z.H. Tan, Santiago Romero-Brufau, Leo Anthony Celi, Dechen Wangmo, Nicolás Della Penna
medRxiv 2021.11.06.21266007; doi: https://doi.org/10.1101/2021.11.06.21266007

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (423)
  • Anesthesia (97)
  • Cardiovascular Medicine (902)
  • Dentistry and Oral Medicine (172)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (408)
  • Epidemiology (8813)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1874)
  • Geriatric Medicine (179)
  • Health Economics (390)
  • Health Informatics (1294)
  • Health Policy (644)
  • Health Systems and Quality Improvement (495)
  • Hematology (207)
  • HIV/AIDS (397)
  • Infectious Diseases (except HIV/AIDS) (10597)
  • Intensive Care and Critical Care Medicine (565)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1770)
  • Nursing (105)
  • Nutrition (267)
  • Obstetrics and Gynecology (344)
  • Occupational and Environmental Health (461)
  • Oncology (968)
  • Ophthalmology (285)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (265)
  • Pediatrics (560)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (221)
  • Psychiatry and Clinical Psychology (1848)
  • Public and Global Health (3998)
  • Radiology and Imaging (657)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (538)
  • Rheumatology (216)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (167)
  • Surgery (199)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)